| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.19 | 9e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.2 | 9e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.18 | 0.0001 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.19 | 0.0001 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0004 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |